𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Parkinson-related genetics in patients treated with deep brain stimulation

✍ Scribed by K. K. Johansen; J. V. Jørgensen; L. R. White; M. J. Farrer; J. O. Aasly

Book ID
109339154
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
95 KB
Volume
123
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gender differences in patients with Park
Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation
✍ Ettore Accolla; Elena Caputo; Filippo Cogiamanian; Filippo Tamma; Simona Mrakic- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract We investigated gender‐differences in clinical phenomenology and response to deep brain stimulation (DBS) of the subthalamic nucleus (STN) in a group of patients with advanced Parkinson's disease (PD). Thirty‐eight consecutive patients with PD (22 men and 16 women), bilaterally implante

Performing functional magnetic resonance
Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation
✍ Paula R. Arantes; Ellison F. Cardoso; Maria Â. Barreiros; Manoel J. Teixeira; Má 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Deep brain stimulation (DBS) is a relatively novel treatment in advanced Parkinson's disease (PD). Functional magnetic resonance imaging (fMRI) is a useful technique for examining the effects of DBS both within the basal ganglia and its cortical connectivity. There are technical difficulties in imag

Health-Related quality of life in patien
Health-Related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei
✍ Helle Just; Karen Ostergaard 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Parkinson's disease (PD) is a progressive neurodegenerative disorder for which there is as yet no cure. It affects many aspects of patients' lives, only some of which can be monitored by available clinical rating scales. In the past decade, there has been a new emphasis on the use of health-related